Rare diseases
Investigational molecules
Locations
Back to Poland1 228 clinical trials in Cracow, Poland across 15 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on the Effects of ARO-MUC5AC Inhalation Solution for Patients with Asthma and COPD
PolandPolandStudy comparing iberdomide, daratumumab and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma
PolandStudy Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension
PolandStudy of Subcutaneous Nivolumab for Patients with Previously Treated Advanced or Metastatic Clear Cell Kidney Cancer
PolandStudy on the Effectiveness and Safety of Golimumab for Children with Moderate to Severe Ulcerative Colitis
PolandStudy on the Safety and Effectiveness of Naronapride for Adults with Moderate Idiopathic or Diabetic Gastroparesis
PolandStudy on the Effectiveness and Safety of NT 201 (Botulinum Toxin) for Treating Lower Limb Spasticity in Adults After Stroke or Traumatic Brain Injury
PolandStudy on Rimegepant for Preventing Migraines in Adults with Poor Response to Oral Preventive Medications
PolandStudy of Lebrikizumab and Mometasone Furoate for Adults with Perennial Allergic Rhinitis
PolandStudy of Lu AG22515 for Adults with Moderate-to-Severe Thyroid Eye Disease
PolandStudy of dupilumab effectiveness compared to placebo in adults with bullous pemphigoid
PolandThe busiest research cities in the country
What the registry says about research in the country
In Kraków, clinical trials in type 2 diabetes, chronic kidney disease, hyperlipidemia, and hypoparathyroidism are exploring new ways to improve long-term disease control and protect organ function.
These studies aim to refine treatment effectiveness and support patients living with chronic metabolic conditions.
A strong group of studies focuses on cardiovascular disease, heart failure, hypertension, atrial fibrillation, and acute myocardial infarction, with the goal of improving prevention and treatment outcomes.
Several trials in the city are also looking at ways to improve recovery after cardiac procedures and lower future cardiovascular risk.
Many trials in Kraków address immune-mediated diseases such as systemic lupus erythematosus, Sjögren’s syndrome, and psoriatic arthritis, with an emphasis on better symptom control and disease suppression.
Research in this area also includes conditions where immune dysfunction affects multiple organs and daily quality of life.
Skin-focused trials cover atopic dermatitis, plaque psoriasis, vitiligo, alopecia areata, and hidradenitis suppurativa, reflecting a broad effort to improve visible and often persistent inflammatory conditions.
These studies aim to offer more effective options for people living with conditions that can strongly affect daily well-being.
Trials in asthma, COPD, chronic rhinosinusitis with nasal polyps, and allergic rhinitis are examining ways to improve breathing, reduce flare-ups, and ease chronic airway inflammation.
Researchers are especially interested in therapies that may lower exacerbation rates and improve everyday respiratory function.
Clinical research in ulcerative colitis, Crohn’s disease, non-alcoholic steatohepatitis, and alcohol-related liver disease is aiming to improve inflammation control and reduce long-term complications.
Some studies also address patients with more complex digestive conditions that need long-term management.
Neurological studies include multiple sclerosis, Alzheimer’s disease, migraine, epilepsy, and narcolepsy, reflecting broad interest in both chronic and progressive brain disorders.
These trials focus on symptom reduction, disease slowing, and better day-to-day functioning for patients with neurological conditions.
Research on breast cancer, non-small cell lung cancer, lymphoma, multiple myeloma, and leukemia is an important part of the trial landscape in Kraków.
These studies seek to improve survival, response rates, and treatment options for both solid tumors and blood-related cancers.
Several trials address genetic and rare diseases such as Marfan syndrome, congenital adrenal hyperplasia, nephrotic syndrome, and other inherited conditions.
These studies are especially valuable for patients with uncommon conditions where treatment choices are limited.
Trials in COVID-19, HIV-1 infection, meningococcal infection, and fungal infections are focused on prevention, treatment, and better disease control.
This area includes both active treatment studies and work aimed at lowering future infection risk.
Studies in juvenile idiopathic arthritis, axial spondyloarthritis, systemic sclerosis, and chronic pain-related disorders are examining ways to reduce inflammation and improve mobility.
Researchers are looking for therapies that can ease stiffness, pain, and movement limitations over time.
Trials involving endometriosis, pregnancy-related conditions, contraception, and menopausal symptoms reflect a broad commitment to women’s health research.
These studies are designed to improve comfort, planning options, and quality of life across different stages of life.
Some trials focus on behavior change, smoking and vaping cessation, and sleep-related problems such as narcolepsy and excessive daytime sleepiness.
These studies combine medical and behavioral approaches to help people improve daily habits and alertness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
